5[1]Grotta JC,Welch KMA,Fagan SC, et al.Clinical deterioration following improvement in the NINDS rt-PA stroke trial. Stroke, 2001,32:661
6[2]Koennecke HC, Nohr R, Leistner S, et al. Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience. Stroke, 2001,32:1074
7[3]Lopez-Yunez AM, Bruno A, Williams LS, et al. Protocol violations in community-based rtPA stroke treatment are associated with symptomatic intracerebral hemorrhage. Stroke, 2001,32:12
8[4]Qureshi AI, Ali Z, Suri MFK, et al. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery, 2001, 49:41
9The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med, 1995, 333(5): 1580-1587.
10Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study(ECASS ).JAMA, 1995, 274 (5): 1017-1025.
